CompletedNCT01422902
Official study titleEvaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach
This study has finished and is no longer accepting participants.
Multiple locations, including Palo AltoSchizophreniaInterventional studyAges 18+
- Countries
- United States
- Sponsor
- Posit Science Corporation
CompletedNCT01378403
Official study titleEvaluation of Dorsal Visual Stream in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Ramat GanSchizophreniaObservational studyAges 18–35
- Countries
- Israel
- Sponsor
- Sheba Medical Center
CompletedNCT00334126
Official study titleA Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Paliperidone ER Compared to Quetiapine in Subjects With an Acute Exacerbation of Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00299702
What is this study about?Researchers compared Risperidal Consta and Abilify to find out how the approaches affected how long people remain free of a new mood episode in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18+
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT03338179
Official study titleEvaluation of Metamemory in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Clermont-FerrandSchizophreniaBehavioural studyAges 18+
- Countries
- France
- Sponsor
- University Hospital, Clermont-Ferrand
CompletedNCT01263080
Official study titleMulticentre Randomised Double-blind, Placebo-controlled 2x2 Factorial Trial Investigating the Effects of Adding Mirtazapine and Folic Acid to Existing Therapy for Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–70
- Countries
- China
- Sponsor
- Capital Medical University
TerminatedNCT02614586
Official study titleA Placebo-Controlled Study to Evaluate the Effect of a Single Dose of TAK-058 and Ondansetron on P50 Auditory Gating in Subjects With Stable Schizophrenia
This study ended early.
In St LouisSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Takeda
CompletedNCT02874560
This study has finished and is no longer accepting participants.
In ParisSchizophreniaObservational studyAges 18–37
- Countries
- France
- Sponsor
- Janssen-Cilag Ltd.
CompletedNCT00445926
Official study titleDeep TMS With the H Coils as a Novel Strategy for the Treatment of Negative Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
In Hod HaSharonSchizophreniaDevice studyAges 18–65
- Countries
- Israel
- Sponsor
- Shalvata Mental Health Center
CompletedNCT00097942
Official study titleA Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients With Persistent Residual Symptoms
This study has finished and is no longer accepting participants.
Multiple locations, including National CitySchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Forest Laboratories
CompletedNCT04087954
This study has finished and is no longer accepting participants.
In AmmanSchizophreniaBehavioural studyAges 18+
- Countries
- Jordan
- Sponsor
- Fakeeh College for Medical Sciences
CompletedNCT04025502
Official study titleA Multi-Center Study of Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSchizophreniaObservational studyAges 21–50
- Countries
- United States
- Sponsor
- ERP Biomarker Qualification Consortium